Atlas Trials

A Clinical Study to Observe the Safety and Efficacy of ScTIL210 in the Treatment of Malignant Solid Tumors

Clinical trial NCT04571892 · UNKNOWN

Trial details

NCT number
NCT04571892
Sponsor
Shanghai East Hospital
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Malignant Solid Tumor
Start date
2020-10-15
Primary completion
2023-12-01
Enrollment
58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.